XNCR moves four new XmAb drug development programs for autoimmune diseases. It also provided favorable updates for two of its oncology drug...
Vous n'êtes pas connecté
DelveInsight, “Hepatocellular Carcinoma Pipeline Insight 2024” report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles,
XNCR moves four new XmAb drug development programs for autoimmune diseases. It also provided favorable updates for two of its oncology drug...
Competitive: Labcorp: About LabCorp Drug Development: As a leading contract research organization, LabCorp provides comprehensive drug development...
Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Police uncovered hundreds of erectile dysfunction tablets, an array of drugs and an imitation penis at Anthony Grant’s 16th-floor apartment, a court...
A new editorial was published in Oncotarget‘s Volume 15 on July 24, 2024, entitled, “Beyond pixels: Graph filtration learning unveils new...
Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA for oral sulopenem to treat adult women with uUTI.
Many individuals worldwide suffer from chronic liver disease (CLD), which poses significant concerns for its tendency to lead to hepatocellular...
MONDAY, Sept. 9, 2024 -- Women with hepatocellular carcinoma (HCC) are less likely to receive a deceased-donor liver transplant (DDLT) and more...